health new england glp 1 coverage High cost of weight-loss drugs strains state Medicaid programs CMS Issues Coverage Guidance on

Eur J Biochem 214:829835 Seino Y, Fukushima M, Yabe D (2010) GIP and GLP-1, the two incretin hormones: similarities and differences

Los GLP-1, o agonistas del receptor del pptido-1 similar al glucagn, son una clase de medicamentos creados para tratar la diabetes tipo 2 al ayudar al pncreas a liberar insulina cuando los niveles de azcar en la sangre estn altos

These drugs are known as glucagon-like peptide-1 (GLP-1) receptor agonists, and they work by mimicking the naturally occurring GLP-1 hormone in the gut

While both medications treat obesity and type 2 diabetes, they work differently

Kim M, Platt MJ, Shibasaki T, Quaggin SE, Backx PH, Seino S, Simpson JA, Drucker DJ: GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure

The food is making us sick and giving us type 2 diabetes, so people are taking these drugs to not eat that toxic food